HHS secretary RFK Jr. said that he would “shut the revolving door to reestablish public trust” in the department.
Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results